Biapenem
CAS No. 120410-24-4
Biapenem( —— )
Catalog No. M17878 CAS No. 120410-24-4
Biapenem is a 1-beta-methylcarbapenem antibiotic with a wide range of antibacterial activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 47 | In Stock |
|
| 50MG | 147 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBiapenem
-
NoteResearch use only, not for human use.
-
Brief DescriptionBiapenem is a 1-beta-methylcarbapenem antibiotic with a wide range of antibacterial activity.
-
DescriptionBiapenem is a 1-beta-methylcarbapenem antibiotic with a wide range of antibacterial activity. Biapenem has similar antibacterial activity to that of imipenem, but is more stable against human renal dehydropeptidase-I and with less neurotoxicity.(In Vitro):Biapenem (CLI 86815) is a carbapenem antibiotic of in vitro antibacterial activity encompassing many Gramnegative and Gram-positive aerobic and anaerobic bacteria, including species producing β-lactamases. Biapenem (CLI 86815) is more stable than imipenem, mero-penem and panipenem to hydrolysis by human renal dihydropeptidase-I (DHP-I), and therefore does not require the coadministration of a DHP-I inhibitor. In randomised, nonblind or double-blind clinical trials, biapenem showed good clinical and bacteriological efficacy (similar to that of imipenem/ cilastatin) in the treatment of adult patients with intra-abdominal infections, lower respiratory infections or complicated urinary tract infections.
-
In VitroBiapenem (CLI 86815) is a carbapenem antibiotic of in vitro antibacterial activity encompassing many Gramnegative and Gram-positive aerobic and anaerobic bacteria, including species producing β-lactamases. Biapenem (CLI 86815) is more stable than imipenem, mero-penem and panipenem to hydrolysis by human renal dihydropeptidase-I (DHP-I), and therefore does not require the coadministration of a DHP-I inhibitor. In randomised, nonblind or double-blind clinical trials, biapenem showed good clinical and bacteriological efficacy (similar to that of imipenem/ cilastatin) in the treatment of adult patients with intra-abdominal infections, lower respiratory infections or complicated urinary tract infections.
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntifungal
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number120410-24-4
-
Formula Weight350.39
-
Molecular FormulaC15H18N4O4S
-
Purity>98% (HPLC)
-
SolubilityH2O : 20 mg/mL 57.08 mM;
-
SMILES[n+]12n(cnc1)CC(C2)SC1=C(N2[C@H]([C@H]1C)[C@H](C2=O)[C@@H](C)O)C(=O)[O-]
-
Chemical Name(4R,5S,6S)-3-((6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-yl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Aldridge KE, et al. Antimicrob Agents Chemother, 1994, 38(4), 889-893.
molnova catalog
related products
-
Isocorypalmine
(-)-Isocorypalmine, a natural product isolated from Corydalis chaerophylla, has significant antifungal activity.
-
Poliumoside
Poliumoside is a natural compound which exhibits significant inhibition of advanced glycation end product formation with IC50 value of 4.6-25.7 μM.
-
Biapenem
Biapenem is a 1-beta-methylcarbapenem antibiotic with a wide range of antibacterial activity.
Cart
sales@molnova.com